We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

204 hedge funds and large institutions have $2.38B invested in Immunomedics Inc in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 85 increasing their positions, 51 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

570% more call options, than puts

Call options by funds: $75.3M | Put options by funds: $11.2M

67% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 51

12% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 26

0% more funds holding

Funds holding: 204 → 204 (0)

29% less capital invested

Capital invested by funds: $3.37B → $2.38B (-$992M)

36% less funds holding in top 10

Funds holding in top 10: 11 → 7 (-4)

Holders
204
Holders Change
–
Holders Change %
0%
% of All Funds
4.43%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.15%
New
29
Increased
85
Reduced
51
Closed
26
Calls
$75.3M
Puts
$11.2M
Net Calls
+$64M
Net Calls Change
+$13.6M

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$49.4M
2
Citadel Advisors
Citadel Advisors
Florida
+$47.8M
3
BC
Boxer Capital
California
+$37.1M
4
BlackRock
BlackRock
New York
+$18.7M
5
DM
Deerfield Management
New York
+$17.9M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$153M
2
O
OrbiMed
New York
-$51.9M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$44.5M
4
Victory Capital Management
Victory Capital Management
Texas
-$40.9M
5
SCM
Scopia Capital Management
New York
-$37.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
76
Guggenheim Capital
Illinois
$2.62M +$156K +10,336 +6%
UBS Group
77
UBS Group
Switzerland
$2.51M +$2.63M +174,477 +2,666%
CRC
78
Curi RMB Capital
Illinois
$2.48M +$452K +30,028 +20%
PPA
79
Parametric Portfolio Associates
Washington
$2.43M +$1.13M +74,967 +75%
Voloridge Investment Management
80
Voloridge Investment Management
Florida
$2.21M +$2.4M +159,677 New
CCM
81
Consonance Capital Management
New York
$2.01M – – –
SW
82
SVB Wealth
Massachusetts
$2.01M – – –
Allianz Asset Management
83
Allianz Asset Management
Germany
$1.96M -$600K -39,865 -22%
Barclays
84
Barclays
United Kingdom
$1.93M +$573K +38,089 +38%
MSL
85
Mackay Shields LLC
New York
$1.9M +$1.36M +90,391 +194%
California Public Employees Retirement System
86
California Public Employees Retirement System
California
$1.84M -$1.02M -67,774 -34%
Millennium Management
87
Millennium Management
New York
$1.84M +$2M +132,684 New
TD Asset Management
88
TD Asset Management
Ontario, Canada
$1.75M -$1.27M -84,406 -40%
CM
89
Caption Management
Oklahoma
$1.73M +$1.88M +125,000 New
Thrivent Financial for Lutherans
90
Thrivent Financial for Lutherans
Minnesota
$1.68M +$23.6K +1,568 +1%
Morgan Stanley
91
Morgan Stanley
New York
$1.66M -$1.33M -88,088 -42%
CSS
92
Cubist Systematic Strategies
Connecticut
$1.6M +$1.7M +112,723 +3,749%
AIG
93
American International Group
New York
$1.54M +$236K +15,651 +16%
SEC
94
Seven Eight Capital
New York
$1.54M +$1.67M +110,980 New
Manulife (Manufacturers Life Insurance)
95
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.51M +$155K +10,272 +10%
CS
96
Credit Suisse
Switzerland
$1.48M +$232K +15,393 +17%
CIBC Private Wealth Group
97
CIBC Private Wealth Group
Georgia
$1.47M +$80.1K +5,325 +5%
ERSOT
98
Employees Retirement System of Texas
Texas
$1.34M +$482K +32,000 +49%
Fidelity International
99
Fidelity International
Bermuda
$1.17M -$246K -16,362 -16%
State Board of Administration of Florida Retirement System
100
State Board of Administration of Florida Retirement System
Florida
$1.16M +$60.9K +4,050 +5%
2 3
4
5 6

IMMU Hedge Fund Activity: Q2 2019 in Review

204 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q2 2019, worth a combined $2.38B — down 29% from $3.37B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new IMMU positions and 26 closed out — a net gain of 3 holders — while 85 added to existing stakes and 51 trimmed.

The largest buyer was Avoro Capital Advisors, adding an estimated $49.4M. The largest seller was Fidelity Investments, cutting an estimated $153M.

  • 204 institutional investors held Immunomedics Inc (IMMU) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $2.38B of Immunomedics Inc stock for Q2 2019, down 29% quarter-over-quarter.
  • 29 funds opened new Immunomedics Inc positions in Q2 2019 and 26 closed out, a net change of +3 holders.
  • The largest Immunomedics Inc buyer in Q2 2019 was Avoro Capital Advisors, an estimated $49.4M added.
  • The largest Immunomedics Inc seller in Q2 2019 was Fidelity Investments, an estimated $153M sold.

Based on aggregated 13F filings for Q2 2019.